Janssen Vaccine Maker Considers Closing Bern Factory

2025-07-02 02:12:59

(MENAFN- Swissinfo) Vaccine developer Janssen is considering closing its factory in the Swiss capital Bern. On Tuesday it opened a consultation procedure with employees to find alternatives. Up to 300 employees could be affected by a plant closure. This content was published on July 2, 2025 - 09:18 2 minutes Keystone-SDA

Français fr Usine bernoise de Janssen menacée de fermer, 300 employés concernés Original Read more: Usine bernoise de Janssen menacée de fermer, 300 employés concerné

+Get the most important news from Switzerland in your inbox

The subsidiary of US pharmaceutical giant Johnson & Johnson said on Tuesday that it was considering closing the Bern plant for two reasons. Firstly, a new vaccine designed to prevent colibacillus infections is not as effective as hoped.

Secondly, the production of lentiviral vectors will soon cease in Bern. The global company Johnson & Johnson is about to inaugurate a new, much larger plant in the Netherlands, according to a press release.

The factory that houses Janssen's operations in Bern has a long history. It was founded in 1898 as the Swiss Institute of Serotherapy and Vaccination.

Translated from German by DeepL/jdp

MENAFN02072025000210011054ID1109753183

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.